Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
HealthCare Global EnterprisesNSE:HCG +0.35%83 Return-on-Tangible-Asset is 0.25% as of Mar. 2026, which is 84% below its 10-year median of 1.52. GuruFocus rates NSE:HCG with a GF Score™ of 83/100 and a GF Value™ of ₹582.93 (Modestly Overvalued). The stock has 2 warning signs investors should review. Among 680 Healthcare Providers & Services companies, HealthCare Global Enterprises ranks worse than 61.76% on this metric.
The historical rank and industry rank for HealthCare Global Enterprises's Return-on-Tangible-Asset or its related term are showing as below:
NSE:HCG'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: -9.6 Med: 1.52 Max: 2.74
Current: 0.43
During the past 12 years, HealthCare Global Enterprises's highest Return-on-Tangible-Asset was 2.74%. The lowest was -9.60%. And the median was 1.52%.
NSE:HCG's Return-on-Tangible-Asset is ranked worse than 61.76% of 680
companies
in the Healthcare Providers & Services industry
Industry Median: 2.465
vs NSE:HCG: 0.43
HealthCare Global Enterprises (NSE:HCG) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
HealthCare Global Enterprises Return-on-Tangible-Asset Related Terms
HealthCare Global Enterprises Return-on-Tangible-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HealthCare Global Enterprises Return-on-Tangible-Asset Chart
NSE:HCG vs HCA, THC, DVA: Return-on-Tangible-Asset Comparison
For the Medical Care Facilities subindustry, HealthCare Global Enterprises's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
HealthCare Global Enterprises Return-on-Tangible-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, HealthCare Global Enterprises's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where HealthCare Global Enterprises's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 0.25% mean?
HealthCare Global Enterprises (NSE:HCG) has a Return-on-Tangible-Asset of 0.25% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on HealthCare Global Enterprises and its competitors. This is 84% below median its historical median of 1.52. According to the industry distribution chart, HealthCare Global Enterprises ranks #420 out of 680 companies in the Healthcare Providers & Services industry, placing it in the top 61.8%.
Is HealthCare Global Enterprises' Return-on-Tangible-Asset too high?
HealthCare Global Enterprises' current Return-on-Tangible-Asset of 0.25% is 84% below median its 10-year median of 1.52. The Healthcare Providers & Services industry median Return-on-Tangible-Asset is 2.47. HealthCare Global Enterprises' value of 0.25% is 89.9% below this industry median. Based on the distribution chart, HealthCare Global Enterprises ranks #420 out of 680 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, HealthCare Global Enterprises has a GF Score™ of 83/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does HealthCare Global Enterprises' Return-on-Tangible-Asset compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, HealthCare Global Enterprises ranks #420 out of 680 companies for Return-on-Tangible-Asset. This places HealthCare Global Enterprises in the lower half of its industry. The industry median Return-on-Tangible-Asset is 2.47. HealthCare Global Enterprises' value of 0.25% is 89.9% below this benchmark. While the company's 10-year median is 1.52 vs. the industry median of 2.47, HealthCare Global Enterprises has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Healthcare Providers & Services company?
The median Return-on-Tangible-Asset among Healthcare Providers & Services companies is 2.47, based on 680 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. HealthCare Global Enterprises's current Return-on-Tangible-Asset of 0.25% is 89.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on HealthCare Global Enterprises and its competitors. For the Healthcare Providers & Services industry, the median Return-on-Tangible-Asset is 2.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. HealthCare Global Enterprises's current Return-on-Tangible-Asset is 0.25%, which is 84% below median its own 10-year median of 1.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is HealthCare Global Enterprises stock overvalued right now?
Based on GuruFocus' analysis, HealthCare Global Enterprises (NSE:HCG) is currently considered Modestly Overvalued. The stock's GF Value™ is ₹582.93, compared to a current price of ₹679.35 — trading 16.5% above its estimated fair value. The current Return-on-Tangible-Asset is 0.25%, which is 84% below median its 10-year median of 1.52 and 89.9% below the Healthcare Providers & Services industry median of 2.47. HealthCare Global Enterprises' overall GF Score™ is 83/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For HealthCare Global Enterprises (NSE:HCG), the current Return-on-Tangible-Asset is 0.25% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is HealthCare Global Enterprises (NSE:HCG) Overvalued in 2026?
Based on GuruFocus' analysis, HealthCare Global Enterprises stock appears to be overvalued.
The current stock price of ₹679.35 is trading 16.5% above its estimated GF Value™ of ₹582.93.
GuruFocus considers HealthCare Global Enterprises to be Modestly Overvalued.
Key valuation signals for NSE:HCG:
Return-on-Tangible-Asset: 0.25% (84% below median its 10-year median of 1.52)
GF Value™: ₹582.93 vs. price of ₹679.35 (16.5% above fair value)
Industry Position: 89.9% below the Healthcare Providers & Services median (#420 of 680)
No single metric tells the full story. See the NSE:HCG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
HealthCare Global Enterprises Business Description
HealthCare Global Enterprises Ltd operates in oncology, providing comprehensive cancer diagnosis and treatment services including medical oncology, radiation therapy, and surgical oncology. It also offers fertility treatment services under the Milann brand, along with multi-specialty hospital care in key medical disciplines. The company's operations span many metropolitan and non-metro cities across India and extend internationally with cancer care centers in Africa. HCG generates revenue through patient services in oncology, fertility treatments, diagnostics, and multi-specialty hospital care, leveraging technology and a networked business model to deliver patient-centric healthcare.
83GF Score
Get the complete analysis for NSE:HCG
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:HCG has been successfully added to your 
